19
Oct-2021

Western Medical Innovation Fellowship startup, Tenomix, receives FACIT funding in collaboration with scientists at Western

ORIGINAL ARTICLE, worldiscoveries.ca, October 18, 2021

Tenomix Team Photo

For the culmination of their work through the 10.5-month program, the 2020-21 cohort of Western Medical Innovation Fellows (MIF) have launched a startup for one of their program projects. Tenomix will help commercialize a bench-top robotic scanning device that can automate the detection of lymph nodes in resected colorectal cancer tissues. The purpose of the device is to help pathology staff shorten sample preparation time, accelerate sample throughput, achieve productivity gains, and contribute to the current standard of care with the use of fewer laboratory resources than existing manual methods.

The nascent company just received six-figure funding from FACIT, a commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation, with a portfolio that has attracted more than $1 billion in investment to Ontario. FACIT receives support through its strategic partner, the Ontario Institute for Cancer Research (OICR), which is funded by the Government of Ontario. FACIT also runs an annual pitch competition for Ontario-based oncology innovations, and selected Tenomix as a finalist in the 2021 event.

To continue reading CLICK HERE

0

 likes / 0 Comments
Share this post: